Annual review of KRAS inhibitors in 2022

克拉斯 癌症研究 化学 癌症 计算生物学 生物 结直肠癌 遗传学
作者
Hao Wang,Lingling Chi,Fuqiang Yu,Honglin Dai,Chao Gao,Xiaojie Si,Zhengjie Wang,Limin Liu,Jiaxin Zheng,Lihong Shan,Hong‐Min Liu,Qiurong Zhang
出处
期刊:European journal of medicinal chemistry [Elsevier]
卷期号:249: 115124-115124 被引量:24
标识
DOI:10.1016/j.ejmech.2023.115124
摘要

Kirsten rat sarcoma viral (KRAS) oncogene is the most commonly mutated isoform of RAS, accounting for 85% of RAS-driven human cancers. KRAS functioning as a signaling hub participates in multiple cellular signaling pathways and regulates a variety of critical processes such as cell proliferation, differentiation, growth, metabolism and migration. Over the past decades, KRAS oncoprotein has been considered as an "undruggable" target due to its smooth surface and high GTP/GDP affinity. The breakthrough in directly targeting G12C mutated-KRAS and recently approved covalent KRASG12C inhibitors sotorasib and adagrasib broke the myth of KRAS undruggable and confirmed the directly targeting KRAS as one of the most promising strategies for the treatment of cancers. Targeting KRASG12C successfully enriched the understanding of KRAS and brought opportunities for the development of inhibitors to directly target other KRAS mutations. With the stage now set for a new era in the treatment of KRAS-driven cancers, the development of KRAS inhibitors also enters a booming epoch. In this review, we overviewed the research progress of KRAS inhibitors with the potential to treat cancers covering articles published in 2022. The design strategies, discovery processes, structure-activity relationship (SAR) studies, cocrystal structure analysis as well as in vitro and in vivo activity were highlighted with the aim of providing updated sight to accelerate the further development of more potent inhibitors targeting various mutated-KRAS with favorable drug-like properties.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
谷雨发布了新的文献求助20
刚刚
2秒前
2秒前
xwq完成签到,获得积分10
2秒前
Captain发布了新的文献求助10
2秒前
涛哥发布了新的文献求助10
3秒前
阿里山完成签到,获得积分10
3秒前
嘟噜发布了新的文献求助20
4秒前
4秒前
4秒前
CipherSage应助111采纳,获得10
5秒前
5秒前
5秒前
华仔应助Elena采纳,获得10
6秒前
InfoNinja应助满意白卉采纳,获得30
6秒前
ffff发布了新的文献求助10
7秒前
叁點水滨发布了新的文献求助10
8秒前
Roxie发布了新的文献求助10
8秒前
深情安青应助WWW采纳,获得10
9秒前
9秒前
9秒前
大个应助涛哥采纳,获得10
9秒前
YMM发布了新的文献求助10
10秒前
cyy发布了新的文献求助10
11秒前
君恪完成签到,获得积分10
11秒前
大模型应助谷雨采纳,获得10
12秒前
念祠发布了新的文献求助10
13秒前
雪雪完成签到 ,获得积分10
13秒前
罗又柔应助myg8627采纳,获得10
13秒前
顾矜应助小吴同志采纳,获得10
13秒前
领导范儿应助小吴同志采纳,获得10
13秒前
我是老大应助小吴同志采纳,获得10
13秒前
尉迟晓筠发布了新的文献求助10
14秒前
立志读博的小胡完成签到,获得积分10
16秒前
姝飞糊涂发布了新的文献求助10
16秒前
17秒前
17秒前
18秒前
18秒前
宋豆豆完成签到 ,获得积分10
19秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Case Research: The Case Writing Process 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141752
求助须知:如何正确求助?哪些是违规求助? 2792736
关于积分的说明 7804057
捐赠科研通 2449017
什么是DOI,文献DOI怎么找? 1303050
科研通“疑难数据库(出版商)”最低求助积分说明 626718
版权声明 601260